This site is intended for healthcare professionals
An oral liquid formulation of Lyrica (pregabalin) is now available from Pfizer.
Originally licensed as an adjunctive therapy for partial seizures with or without secondary generalisation, the gamma-aminobutyric acid (GABA) analogue is also licensed for generalised anxiety disorder and for the treatment of peripheral and central neuropathic pain.
The oral solution contains 20mg pregabalin per ml. It is available in a 473ml bottle pack and also contains a graduated oral syringe with adaptor.
View Lyrica Oral Solution drug record
Further information: Pfizer
The MHRA has limited the use of the adjunctive anti-epileptic...
Lyrica (pregabalin) has been approved for the treatment...
The licensed indications for Lyrica (pregabalin) have...
The most up-to-date drug information at your fingertips.
Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.
Formulations, doses and costs of osteoporosis supplements.
Available presentations of bronchodilators and anti-inflammatories.
Strengths and formulations of topical steroids.
Potential sensitising agents in topical steroids.
Drugs
Conditions
Articles